Press release
Multiomics Market to Hit USD 14.92 Billion by 2030
Multiomics Market
Sub-Headline: The global Multiomics Market is projected to grow from USD 6.45 billion in 2023 to USD 14.92 billion by 2030, expanding at an impressive CAGR of 12.8%, driven by next-generation sequencing (NGS), AI-enabled analytics, and rising investments in precision medicine.
Introduction
The Multiomics Market is entering a hyper-growth phase as healthcare, biotechnology, and pharmaceutical industries increasingly adopt integrated omics platforms-including genomics, transcriptomics, proteomics, metabolomics, epigenomics, and lipidomics-to achieve holistic biological insights.
By combining multiple omics layers, multiomics enables unparalleled understanding of disease pathways, drug targets, tumor heterogeneity, immune responses, aging biology, and personalized therapeutic responses. With stronger investments in precision oncology, AI-driven data interpretation, and multiomics-based biomarker discovery, global demand is rising rapidly.
'Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73501
Key Takeaways
• Market Size (2023): USD 6.45 Billion
• Expected Market Size (2030): USD 14.92 Billion
• CAGR (2024-2030): 12.8%
• Multiomics adoption rising sharply across oncology, immunology, neurology, and rare disease diagnostics.
• Key players: Thermo Fisher Scientific, Illumina, Danaher (Cytiva), Qiagen, Agilent Technologies, Bruker, PerkinElmer, Pacific Biosciences, Waters Corporation, 10x Genomics, and BGI Genomics.
• AI/ML-based omics interpretation platforms are accelerating adoption in clinical research.
Market Story
Multiomics represents the next frontier in life sciences, enabling simultaneous measurement and integration of multiple molecular layers:
• Genomics - DNA mutations, variants, structural changes
• Transcriptomics - RNA expression patterns
• Proteomics - protein function and signaling
• Metabolomics - metabolic pathways & biochemical reactions
• Epigenomics - DNA methylation, histone modifications
• Lipidomics - lipid signatures in diseases
This integrated approach provides a 360° molecular view that is unattainable with single-omics methods.
Breakthroughs such as:
• Single-cell multiomics
• Spatial omics & spatial transcriptomics
• Long-read sequencing
• AI-enabled biomarker discovery
• Multiomics for drug response prediction
• Mass spectrometry and high-throughput proteomics
are transforming precision medicine and targeted therapy development.
Industries across pharma, biotechnology, diagnostics, and academic research are increasingly incorporating multiomics in biomarker discovery, clinical trial optimization, vaccine development, immunology research, aging studies, and rare disease profiling.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73501/multiomics-market
Market Segments
By Type
• Genomics
• Proteomics
• Transcriptomics
• Metabolomics
• Epigenomics
• Integrated Multiomics Platforms
By Offering
• Consumables (largest share; recurring revenue source)
• Instruments (NGS systems, mass spectrometers, microarrays)
• Services (sequencing, proteomics, bioinformatics)
• Software & Analytics Platforms
By Technology
• Next-Generation Sequencing (NGS)
• Mass Spectrometry
• Single-Cell Multiomics
• Chromatography (HPLC/UPLC)
• Microarrays
• Bioinformatics & AI Tools
By Application
• Oncology & Precision Oncology (fastest-growing)
• Immunology & Vaccine Development
• Neurological & Neurodegenerative Diseases
• Drug Discovery & Toxicology
• Aging & Regenerative Medicine
• Microbiome Research
• Rare Disease Diagnostics
By End User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Clinical Laboratories & Hospitals
• Contract Research Organizations (CROs)
Recent Developments
• Thermo Fisher Scientific expanded its multiomics workflow with advanced Orbitrap mass spectrometers for deeper proteomic profiling.
• 10x Genomics launched integrated single-cell multiomics platforms combining DNA, RNA, and protein analysis.
• Illumina introduced new long-read sequencing solutions enhancing structural variant detection for multiomics studies.
• Qiagen rolled out automated sample prep systems supporting multiomics workflows.
• Bruker upgraded its timsTOF proteomics systems for ultra-high sensitivity.
• Danaher/Cytiva strengthened multiomics analytics through AI-enabled platforms.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73501
Expert Quote
"Multiomics is redefining modern biology by enabling clinicians and researchers to understand diseases at every molecular layer. This capability is powering the next generation of targeted therapies, early diagnostics, and precision medicine strategies."
-Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Market Drivers
• Growing demand for precision medicine & individualized therapy
• Rising cancer prevalence requiring advanced molecular profiling
• Rapid adoption of single-cell and spatial multiomics
• Expansion of AI/ML-based omics interpretation platforms
• Increased R&D investment from pharma & biotech companies
• Advancement of long-read sequencing & mass spectrometry
• Government-funded population genomics & multiomics initiatives
Forecast Outlook
The Multiomics Market is expected to exceed USD 14.92 billion by 2030, driven by:
• Clinical adoption of multiomics-based diagnostics
• Integrative omics used in drug discovery pipelines
• Rapid growth in spatial omics and single-cell sequencing
• Multiomics-based patient stratification in clinical trials
North America leads due to strong genomics infrastructure.
Asia-Pacific is the fastest-growing region with national genomics missions in China, Japan, South Korea, India, and Singapore.
Government & Regulatory Initiatives
• National precision medicine programs (USA, China, EU, India)
• NIH and NCI funding for multiomics cancer research
• EU Horizon investments in integrative omics platforms
• FDA frameworks supporting omics-based biomarkers
• Population genomics projects integrating multiomics datasets
Conclusion
The Multiomics Market is advancing rapidly, enabling deeper insights into disease mechanisms and empowering personalized healthcare. Companies that invest in AI-driven analytics, long-read sequencing, high-throughput proteomics, and single-cell multiomics will lead the next decade of biomedical innovation.
This report is also available in the following languages : Japanese (マルチオミクス市場), Korean (멀티오믹스 시장), Chinese (多组学市场), French (Marché multiomique), German (Multiomics-Markt), and Italian (Mercato Multiomics), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73501
Our More Reports:
Cell Sorting Market
https://exactitudeconsultancy.com/reports/73539/cell-sorting-market
Pharmaceutical Spray Drying Market
https://exactitudeconsultancy.com/reports/73539/cell-sorting-market
Bio/Pharmaceutical Outsourcing Market
https://exactitudeconsultancy.com/reports/73627/bio-pharmaceutical-outsourcing-market
Bronchitis Clinical Market
https://exactitudeconsultancy.com/reports/73629/bronchitis-clinical-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiomics Market to Hit USD 14.92 Billion by 2030 here
News-ID: 4295139 • Views: …
More Releases from Exactitude Consultancy
Collaborative Robot Market is expected to reach USD 8.1 billion by 2034
Market Overview
The Collaborative Robot (Cobot) Market encompasses robotic systems designed to work safely alongside humans. Unlike traditional industrial robots that operate in isolated zones, cobots enhance flexibility, efficiency, and safety across manufacturing, logistics, healthcare, electronics, automotive, education, and food & beverage sectors.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73716
In 2024, the global market is valued at USD 2.6 billion, driven by workforce shortages, the rise of Industry 4.0,…
Sustainable Laboratory Plasticware Market to Reach USD 3.42 Billion by 2030
Sub-Headline: The global Sustainable Laboratory Plasticware Market is projected to grow from USD 1.85 billion in 2023 to USD 3.42 billion by 2030, expanding at a CAGR of 9.1%, driven by rising environmental regulations, bio-based polymer adoption, and waste-reduction initiatives across laboratories.
Introduction
The Sustainable Laboratory Plasticware Market is gaining strong global momentum as academic laboratories, pharmaceutical manufacturers, research institutes, and diagnostic centers transition from traditional petroleum-based plasticware to eco-friendly, recyclable, and…
Single-Cell Omics Market to Reach USD 10.74 Billion by 2030 as Multi-Omics & Pre …
Sub-Headline: The global Single-Cell Omics Market is expected to grow from USD 4.12 billion in 2023 to USD 10.74 billion by 2030, registering a robust CAGR of 14.6%, driven by rapid advances in single-cell sequencing, spatial omics, immunology research, and multi-omics integration.
Introduction
The Single-Cell Omics Market is undergoing explosive expansion as researchers seek deeper insights into cellular diversity, gene expression variability, epigenetic signatures, and molecular activity at single-cell resolution. Unlike bulk…
AI in Drug Discovery Market is projected to reach USD 19.52 billion by 2034
Market Overview
The AI in Drug Discovery Market includes machine learning platforms, deep learning engines, generative AI tools, bioinformatics software, neural network-powered molecular profiling systems, and automation technologies that accelerate drug design, molecule screening, target assessment, and lead optimization.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73714
In 2024, the market value stands at USD 3.21 billion, driven by:
• Increasing R&D spending by pharma and biotech
• Growing availability of large-scale biological and chemical…
More Releases for Multiomics
Multiomics Market to Reach USD 17.8 Billion by 2034
In the era of precision medicine, understanding diseases at the molecular level is critical for developing effective diagnostics and therapies. Multiomics-the integration of multiple "omics" technologies such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics-has become a transformative approach in biomedical research. By combining insights across these domains, researchers can build a holistic view of biological systems, identify biomarkers, and tailor treatments to individual patients.
Download Full PDF Sample Copy of Market…
Key Trends Influencing the Growth of the Multiomics Market in 2025: Innovative S …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Multiomics Market Through 2025?
The size of the multiomics market has seen swift expansion in the past few years. It is projected to rise from $3.27 billion in 2024, hitting $3.85 billion in 2025. This growth signifies a compound annual growth rate…
Growth Of Precision Medicine Boosts Single Cell Multiomics Market: A Key Driver …
The Single Cell Multiomics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Single Cell Multiomics Market Size and Its Estimated Growth Rate?
In recent times, the single cell multiomics market has experienced significant expansion. The anticipated growth will be from $3.97 billion…
Rising Demand For Personalized Medicine Fuels Growth Of The Multiomics Market: A …
The Multiomics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Multiomics Market Size and Projected Growth Rate?
The multiomics market has shown rapid growth in recent years. It will grow from $3.27 billion in 2024 to $3.85 billion in 2025 at a CAGR…
Growth Of Precision Medicine Boosts Single Cell Multiomics Market: Major Factor …
How Will the Single Cell Multiomics Market Grow, and What Is the Projected Market Size?
The market size for single cell multiomics has seen a tremendous expansion in recent years. The growth is expected to move from $3.97 billion in 2024 to $4.85 billion in 2025, marking an impressive Compound Annual Growth Rate (CAGR) of 22.1%. The exceptional growth during the historical period can be tied to factors such as the…
Key Multiomics Market Trend for 2025-2034: Innovative Single-Cell Multiomics Pla …
"What Is the Future Outlook for the Multiomics Market's Size and Growth Rate?
The size of the multiomics market has seen a quick expansion lately. It is projected to increase from $3.27 billion in 2024 to $3.85 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. The noteworthy growth in the past period is due to factors such as the hike in biomedical research, augmented governmental and private…
